Details for Patent: 12,064,399
✉ Email this page to a colleague
Which drugs does patent 12,064,399 protect, and when does it expire?
Patent 12,064,399 protects EPIDIOLEX and is included in one NDA.
This patent has sixteen patent family members in nine countries.
Drugs Protected by US Patent 12,064,399
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF FOCAL SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME | ⤷ Sign Up | ||||
Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF FOCAL SEIZURES ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,064,399
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016278088 | ⤷ Sign Up | |||
Australia | 2021269374 | ⤷ Sign Up | |||
Canada | 2989779 | ⤷ Sign Up | |||
European Patent Office | 3310390 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |